126 related articles for article (PubMed ID: 7555373)
1. [Hypomagnesemia in patients of gynecologic neoplasms following chemotherapy with cisplatin].
Li L; Huang W; Zhu B
Zhonghua Fu Chan Ke Za Zhi; 1995 Jun; 30(6):363-5. PubMed ID: 7555373
[TBL] [Abstract][Full Text] [Related]
2. Hypomagnesemia after cisplatin combination chemotherapy.
Buckley JE; Clark VL; Meyer TJ; Pearlman NW
Arch Intern Med; 1984 Dec; 144(12):2347-8. PubMed ID: 6542342
[TBL] [Abstract][Full Text] [Related]
3. Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer.
Schilsky RL; Barlock A; Ozols RF
Cancer Treat Rep; 1982 Sep; 66(9):1767-9. PubMed ID: 6889461
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and hypomagnesemia.
Lajer H; Daugaard G
Cancer Treat Rev; 1999 Feb; 25(1):47-58. PubMed ID: 10212589
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-induced hypocalcemia and hypomagnesemia.
Lyman NW; Hemalatha C; Viscuso RL; Jacobs MG
Arch Intern Med; 1980 Nov; 140(11):1513-4. PubMed ID: 7192079
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure.
Gomez Campdera FJ; Gonzalez P; Carrillo A; Estelles MC; Rengel M
Int J Pediatr Nephrol; 1986; 7(3):151-2. PubMed ID: 3804580
[TBL] [Abstract][Full Text] [Related]
7. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
Stöhr W; Paulides M; Bielack S; Jürgens H; Koscielniak E; Rossi R; Langer T; Beck JD
Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
[TBL] [Abstract][Full Text] [Related]
8. Refractory potassium repletion due to cisplatin-induced magnesium depletion.
Rodriguez M; Solanki DL; Whang R
Arch Intern Med; 1989 Nov; 149(11):2592-4. PubMed ID: 2818117
[TBL] [Abstract][Full Text] [Related]
9. Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature.
Al-Tweigeri T; Magliocco AM; DeCoteau JF
Gynecol Oncol; 1999 Jan; 72(1):120-2. PubMed ID: 9889044
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cisplatin-induced hypomagnesemia.
Kibirige MS; Morris-Jones PH; Addison GM
Pediatr Hematol Oncol; 1988; 5(1):1-6. PubMed ID: 3152946
[TBL] [Abstract][Full Text] [Related]
11. Ionised and total serum magnesium in renal transplant patients.
Mazzaferro S; Barberi S; Scarda A; Pasquali M; Rubino F; D'Erasmo E
J Nephrol; 2002; 15(3):275-80. PubMed ID: 12113599
[TBL] [Abstract][Full Text] [Related]
12. Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.
Yamamoto Y; Watanabe K; Tsukiyama I; Yabushita H; Matsuura K; Wakatsuki A
Anticancer Res; 2016 Apr; 36(4):1873-7. PubMed ID: 27069173
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-induced hypomagnesemia and cardiac dysrhythmia.
Bashir H; Crom D; Metzger M; Mulcahey J; Jones D; Hudson MM
Pediatr Blood Cancer; 2007 Nov; 49(6):867-9. PubMed ID: 16619211
[TBL] [Abstract][Full Text] [Related]
14. Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer.
Markmann M; Rothman R; Reichman B; Hakes T; Lewis JL; Rubin S; Jones W; Almadrones L; Hoskins W
J Cancer Res Clin Oncol; 1991; 117(2):89-90. PubMed ID: 2007614
[TBL] [Abstract][Full Text] [Related]
15. Magnesium homeostasis following chemotherapy with cisplatin: a prospective study.
Stewart AF; Keating T; Schwartz PE
Am J Obstet Gynecol; 1985 Nov; 153(6):660-5. PubMed ID: 4061536
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity.
Connelly E; Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Gynecol Oncol; 1996 Aug; 62(2):166-8. PubMed ID: 8751544
[TBL] [Abstract][Full Text] [Related]
17. cis-Platinum-induced hypomagnesemia and peripheral neuropathy.
Ashraf M; Scotchel PL; Krall JM; Flink EB
Gynecol Oncol; 1983 Dec; 16(3):309-18. PubMed ID: 6317526
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial.
Tantipalakorn C; Srisomboon J; Thienthong H; Pantusart A; Suprasert P; Saereesongkhun C; Eamtang S; Sutthichat A; Pautad N
J Med Assoc Thai; 2004 Feb; 87(2):119-25. PubMed ID: 15061293
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin administration to gynecologic cancer patients. Long-term effects on hearing.
Laurell G; Beskow C; Frankendal B; Borg E
Cancer; 1996 Oct; 78(8):1798-804. PubMed ID: 8859195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
